Press Releases
Oxilio and Quotient Sciences Announce Regulatory Approval for Oxilio’s OXL001 Development Program
Oxilio, a pioneering drug development company repurposing existing drugs to address unmet needs in cancer treatment, and Quotient Sciences, a drug development and manufacturing...
Press Releases
Velocity Clinical Research reveals findings from US patient survey on decentralization in clinical research
Velocity Clinical Research (“Velocity”), the leading integrated research site organization with 40 locations across 19 U.S. states and Europe, announces the findings of its...
Drug Research
Daiichi Sankyo Blood Cancer Drug Ezharmia Approved In Japan
Daiichi Sankyo, a Japanese company, has been concentrating on a series of antibody-drug conjugates, but it has achieved a world first in a field...
Drug Research
Biden Medicare Benefits Due To Alzheimers Medicine Shift
Despite the fact that the decision to severely restrict coverage of an expensive new Alzheimer's medicine, U.S. President Joe Biden celebrated success on September...
Press Releases
Quanticate partners with Cancer Research UK to launch DETERMINE Study
Quanticate, a global data-focused clinical research organisation (CRO), has partnered with leading cancer research organisation, Cancer Research UK, to launch the DETERMINE study which...
Press Releases
Monon Bioventures receives nearly $400,000 to develop Purdue-discovered glioblastoma treatment
Monon Bioventures LLC has received a one-year, $398,314 Phase I Small Business Innovation Research, or SBIR, grant from the National Cancer Institute to demonstrate the...
Interviews
Developing a systematic quality approach for injectable drug products
For prefilled drug delivery systems – from a syringe to a complex wearable – the main goal of the aseptic manufacturing process is to...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read